Therapeutic Strategies Utilized in the Setting of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

Ítems similars

• Combating acquired resistance to tyrosine kinase inhibitors in lung cancer
  per: Lovly, Christine M.
  Publicat: (2015)
• Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors
  per: Yu, Helena A., et al.
  Publicat: (2013)
• Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors
  per: Westover, D, et al.
  Publicat: (2018)
• New Strategies in Overcoming Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer
  per: Oxnard, Geoffrey R., et al.
  Publicat: (2011)
• Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic Strategies
  per: Lovly, Christine M., et al.
  Publicat: (2014)